• Home
  • About
  • Contact
  • Privacy
  • DCMA
  • Terms
  • Sitemap
  • Submit
Oscar Times
  • Home
  • Celebrity
  • Entertainment
  • Fashion
  • Fitness
  • Health
No Result
View All Result
Oscar Times
  • Home
  • Celebrity
  • Entertainment
  • Fashion
  • Fitness
  • Health
No Result
View All Result
Oscar Times
No Result
View All Result
Home Health

Olive exaggerates cost savings; Happify Health reports DTx curbs anxiety in psoriasis patients; and other digital health briefs

April 9, 2022
Reading Time: 3 mins read
0
Olive exaggerates cost savings; Happify Health reports DTx curbs anxiety in psoriasis patients; and other digital health briefs
Share on FacebookShare on TwitterShare on LinkedinShare on PinterestShare on Reddit

Axios’  Erin Brodwin published a new investigation which discovered healthcare automation startup Olive is exaggerating its capabilities and only uses “rough estimations” to gauge its cost savings. According to the report, Olive, which promises health systems cost savings, is only tracking savings if a client requests it. The report also highlighted Olive employees’ concerns about how the company handles patient health information. 

This report comes less than a year after the company closed a whopping $400 million investment round, which brought its valuation to $4 billion. 

RELATED STORIES

The Incredible Benefits of Seeing an Orthodontist – HealthPhreaks

Colon cancer screening decisions: What’s the best option and when?

June 30, 2022
lemongrass tea

5 Therapeutic Reasons Why This Aromatic Tea Is Awesome

June 29, 2022

Digital therapeutic company Happify released results of its real-world psoriasis data analysis. Researchers found that patients with psoriasis who completed 16 Happify activities within a minimum of six weeks reported a 27% reduction in anxiety symptoms and a 27% boost in subjective wellbeing.

Meanwhile, the study reports that individuals who completed less than 16 activities improved their wellbeing score by 4.11% and reduced their anxiety score by 8.15%. 

The research was conducted by Happify Health and is not yet published in an academic journal.

Oura, maker of a ring health-tracking wearable, announced earlier this week its valuation had reached $2.55 billion. 

Though the company didn’t release further details, a spokesperson told MobiHealthNews it had raised an “oversubscribed” funding round. Oura said the new investment will go toward research and development, personalized content and product innovation.

The startup most recently scooped up $100 million in Series C financing in May 2021. 

Oura revealed its Oura Ring Generation 3 in October. The wearable maker said workout heart rate monitoring, blood-oxygen sensing and an improved sleep algorithm will be added to the new wearable later in 2022. 

Digital pharmacy and telehealth startup Truepill is partnering with COVID-19 testing company Curative to offer patients access to Truepill’s COVID-19 virtual care platform.

When a customer tests positive at one of Curative’s testing sites, they can receive telehealth consults and antiviral medications through the platform if eligible. Truepill announced its COVID-19-focused virtual care offering in early December. 

This isn’t Truepill’s only virtual tool aimed at managing the pandemic. In January, it launched a test coverage platform to assist payers in developing their own direct-to-consumer test-purchasing sites, with Truepill fulfilling and shipping orders. In March 2021, the company rolled out a suite of diagnostics, medication delivery and contact-tracing tools for the employer market. 

“Access, speed and scale are essential to any COVID-19 response, and this is especially true when it comes to the distribution of antiviral medications,” Truepill CEO and cofounder Sid Viswanathan said in a statement.

“We’re thrilled to partner with diagnostic testing leader Curative to provide an end-to-end, white-labeled virtual care experience that enables efficient, streamlined access to treatment.”

Source by www.mobihealthnews.com

Trending Topics

  • *deep breath* Big changes. – Blogilates
  • Colon cancer screening decisions: What’s the best option and when?
  • The 14 Best Sunscreens for Acne-Prone Skin
  • Rare Beauty Kind Words Matte Lipstick & Liner 10 Swatches
  • Paddy McGuinness and wife Christine split? TV star sparks rumours
  • American Cheese – A Gluten-Free Alternative
  • 5 Therapeutic Reasons Why This Aromatic Tea Is Awesome

About Us

Oscar Times! possesses a brand that is globally recognizable and multiplatform. Get the latest news about music, sports, movies, pop culture, fashion, beauty, fitness, and politics at your fingertips.

Learn more

Recent Stories

  • *deep breath* Big changes. – Blogilates
  • Colon cancer screening decisions: What’s the best option and when?
  • The 14 Best Sunscreens for Acne-Prone Skin
  • Rare Beauty Kind Words Matte Lipstick & Liner 10 Swatches
  • Paddy McGuinness and wife Christine split? TV star sparks rumours
  • American Cheese – A Gluten-Free Alternative
  • 5 Therapeutic Reasons Why This Aromatic Tea Is Awesome

Categories

  • Auto
  • Awards
  • Babies
  • Beauty
  • Business
  • Celebrity
  • Culture
  • Dating
  • Entertainment
  • Fashion
  • Fitness
  • Food
  • Fragrance
  • Games
  • Hair Care
  • Health
  • Makeup
  • Marketing
  • Movies
  • Music
  • Outfits
  • Real Estate
  • Skincare
  • Tech
  • Travel
  • TV Shows
  • Web Series

Follow Us

Submit A News | Write For Us

Feel free to contact us for submissions queries. Email: [email protected]

  • Home
  • About
  • Contact
  • Privacy
  • DCMA
  • Terms
  • Sitemap
  • Submit

© 2021 Oscartimes.com

No Result
View All Result
  • Home
    • Home – Layout 1
    • Home – Layout 2
    • Home – Layout 3
  • Landing Page
  • Buy JNews
  • Support Forum
  • Pre-sale Question
  • Contact Us